Abstract
Aim:
To perform a site-specific conjugation of Fab′ fragments of a mouse monoclonal antibody(MoAb) B43(of IgG1 subtype) to a bifunctional chelator 6-[p- (bromoacetamido) benzyl]-1,4,8,11-tetraazacyclotetradecane-N,N′,N″,N′″-tetraacetic acid (BAT) via the thiol groups in the hinge distal to the antigenbinding site of the Fab′.
Methods:
B43 was cleaved using a simple 2-step method. First, stable F(ab′)2 was produced by pepsin treatment. Fab′ with free thiol in the hinge region was then obtained by cysteine reduction of F(ab′)2. Second, a site-specific conjugation of Fab′ to thiol-specific BAT was performed in a one-step reaction.
Results:
The Fab′ fragment had approximately 1.8 free thiol groups per molecule after cysteine reduction. The conjugation efficiency and the chemical yield were approximately 1.28 moles chelator/Fab′ and 74% of the initial concentration of Fab′, respectively. The F(ab′)2, Fab′ and Fab′-BAT all maintained reasonable antigen-binding properties. 67Cu labeling of the conjugate under standard conditions did not impair the immunoreactivity of Fab′-BAT.
Conclusion:
This is a simple and efficient method for producing immunoreactive conjugates of Fab′- BAT, which can be used to make radiometal-labeled conjugates for further diagnostic and therapeutic applications.
Similar content being viewed by others
Article PDF
References
Sundaresan G, Yazaki PJ, Shively JE, Finn RD, Larson SM . 124I-labeled engineered anti-CEA minibodies and diabodies allow highcontrast, antigen-specific small-animal PET imaging of xenografts in athymic mice. J Nucl Med 2003; 44: 1962–9.
Neumaier M, Gaida FJ, Lewis MR, Hefta LJ, Shively LE . A chimeric anti-CEA antibody with heavy interchain disulfide bonds deleted: molecular characterization and biodistributions in normal and tumor bearing mice. Anticancer Res 1999; 19: 13–21.
Lu ZR, Shiah JG, Sakuma S, Kopeckova P, Kopecek J . Design of novel bioconjugates for targeted drug delivery. J Control Release 2002; 78: 165–73.
Dhawan S . Design and construction of novel molecular conjugates for signal amplification (I): conjugation of multiple horseradish peroxidase molecules to immunoglobulin via primary amines on lysine peptide chains. Peptides 2002; 23: 2091–8.
Hashida S, Imagawa M, Inoue S, Ruan KH, Ishikawa E . More useful maleimide compounds for the conjugation of Fab' to horseradish peroxidase through thiol groups in the hinge. J Appl Biochem 1984; 6: 56–63.
Govindon SV, Goldenberg DM, Griffiths GL, Leung S, Losman MJ, Hansen HJ . Site-specific modification of light chain glycosylated antilymphoma(LL2) and anti-carcinoembryonic antigen(hImmu-14-N) antibody divalent fragments. Cancer Res 1995; 55: 5721s–5725s.
Griffiths GL, Goldenberg DM, Roesch F, Hansen HJ . Radiolabeling of an anti-carcinoembryonic antigen antibody Fab′ fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m. Clin Cancer Res 1999; 5: 3001s–3003s.
Smith A, Alberto R, Blaeuenstein P, Novak-Hofe I, Maecke H, Schubiger PA . Pre-clinical evaluation of 67Cu-labeled intact and fragmented anti-colon-carcinoma monoclonal antibody MAb35. Cancer Res 1993; 66: 5727–33.
Stimmel JB, Merrill BM, Kuyper LF, Moxham CP, Hutchins JT . Site-specific conjugation of serine → cysteine variant monoclonal antibodies. J Biol Chem 2000; 275: 30445–50.
Lewis MR, Boswell CA, Laforest R, Buettner TL, Ye D . Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3. Cancer Biother Radiopharm 2001; 16: 483–94.
O'Donnell RT, Shen S, Denardo SJ, Wun T, Kukis DL . A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma. Anticancer Res 2000; 20: 3647–55.
Riddles PW, Blakeley RL, Zerner B . Reassessment of Ellman's reagent. Meth Enzymol 1983; 91: 49–60.
Anderson CJ, Connett JM, Schwarz SW . Copper-64-labeled antibodies for PET imaging. J Nucl Med 1992; 33: 1685–91.
Mirick GR, O'Donnell RT, DeNardo SJ, Shen S, Meares CF . Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients. Nucl Med Biol 1999; 26: 841–5.
Kukis DL, DeNardo GL, DeNardo SJ, Mirick GR, Miers LA . Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates. Cancer Res 1995; 55: 878–84.
Weston PD, Devries JA, Wrigglesworth R . Conjugation of enzymes to immunoglobulins using dimaleimides. Biochem Biophys Acta 1980; 612: 40–9.
Imagawa M, Hashida S, Ishikawa E, Sumiyoshi A . Evaluation of Fab'-horseradish peroxidase conjugates prepared using pyridyl disulfide compounds. J Appl Biochem 1982; 4: 400–10.
Wilbur DS, Stray JE, Hamlin DK, Curtis DK, Vessella RL . Monoclonal antibody Fab′ fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab′)2 fragments. Bioconjug Chem 1994; 5: 220–35.
McCall MJ, Diril H, Meares CF . Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane. Bioconjugate Chem 1990; 1: 222–6.
Smith-Jones PM, Fredrich R, Kaden TA, Novak-Hofer I, Siebold K . Antibody labeling with copper-67 using the bifunctional macrocycle 4-[(1,4,8,11-tetraazacyclotetradec-l-yl)methy] benzoic acid. Bioconjugate Chem 1991; 2: 415–21.
Albrecht H, Burke PA, Natarajan A, Xiong CY, Kalicinsky M . Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand. Bioconjug Chem 2004; 15: 16–26.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, J., Wang, Xh., Wang, Xm. et al. Site-specific conjugation of bifunctional chelator BAT to mouse IgG1 Fab' fragment. Acta Pharmacol Sin 27, 237–241 (2006). https://doi.org/10.1111/j.1745-7254.2006.00242.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00242.x
Keywords
This article is cited by
-
Site-Specifically Labeled Immunoconjugates for Molecular Imaging—Part 1: Cysteine Residues and Glycans
Molecular Imaging and Biology (2016)